FindTrial
Sign In

DEVELOPMENT OF AMA ASSESSMENT TOOL AND KNOW THE EFFECT OF AMA ON PRO-INFLAMATORY MARKER

To Develop a Diagnostic Tool to Assess and Establish Ama as a Pro-inflamatory Marker - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/09/057837
Enrollment
20
Registered
2023-09-19
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R768- Other specified abnormal immunological findings in serum Health Condition 2: K928- Other specified diseases of the digestive system

Interventions

None listed

Sponsors

KLE Academy of Higher education and research belagavi karnataka
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Group A 1. Individual between 20 years to 30 years of age and with signs and symptoms of AMA (Ashtang hridya) 2. With no systemic diseases. Group B • Healthy individual with no symptoms of ama and no systemic disease/inflammation.

Exclusion criteria

Exclusion criteria: ? Patients >20 years and ? Patients with Samshrishta Dosha (chronic stage). ? Patients with systemic disease like diabetes, kidney disease, cancer, cardiovascular disease, dyslipidemia, rheumatoid arthritis, IBD, Alzheimerâ??s and Parkinsonâ??s disease.

Design outcomes

Primary

MeasureTime frame
association of inflammatory markers with amaTimepoint: after the analysis of the result i.e at 6 months—

Secondary

MeasureTime frame
ama association with digestive inflammtory marker at the end of the studyTimepoint: after the analysis of the at 6 months—

Countries

India

Contacts

Public ContactGiridhar vedantam

KAHERâ??sShri BMK Ayurveda Mahavidyalaya Belagavi

drgiridharay@gmail.com9731028625

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026